Literature DB >> 7835952

Interleukin-5 mRNA levels in blood and bone marrow mononuclear cells from patients with the idiopathic hypereosinophilic syndrome.

T Satoh1, L Sun, M S Li, C J Spry.   

Abstract

High blood eosinophil counts in humans are usually due to parasitic infections, allergic processes or malignant diseases. Interleukin-5 (IL-5) is thought to be the principal eosinopoietic stimulus in most of these patients. As the causes of persistent eosinophilia in patients with the idiopathic hypereosinophilic syndrome (HES) are (by definition) unknown, a semi-quantitative assay for IL-5 mRNA in eosinophils and mononuclear cells was carried out using samples from 11 patients with HES. In three patients, unstimulated peripheral blood mononuclear cells (PBMC) and bone marrow mononuclear cells (BMMC) had markedly raised levels of IL-5 mRNA. In four of five patients studied, phorbol myristate acetate (PMA) stimulation of PBMC induced them to produce more IL-5 mRNA than four healthy subjects. In five patients, bone marrow IL-5 mRNA levels were related to blood eosinophil counts. Blood eosinophils from all six patients tested, and bone marrow granulocytes from four patients had undetectable levels of IL-5 mRNA. It was concluded that HES can be separated into two groups. One has high levels of IL-5 mRNA and/or an enhanced IL-5 mRNA response to stimulation. They may well respond to treatments which inhibit the effects of this cytokine on eosinophil progenitor cells. The second group appears to have a disease which is IL-5 independent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835952      PMCID: PMC1414943     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Molecular cloning and structure of the human interleukin-5 gene.

Authors:  T Tanabe; M Konishi; T Mizuta; T Noma; T Honjo
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

2.  Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns.

Authors:  S Nakajima-Iijima; H Hamada; P Reddy; T Kakunaga
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 4.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

5.  Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.

Authors:  P Ponte; S Y Ng; J Engel; P Gunning; L Kedes
Journal:  Nucleic Acids Res       Date:  1984-02-10       Impact factor: 16.971

Review 6.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

7.  Parallel regulation of IL-4 and IL-5 in human helminth infections.

Authors:  S Mahanty; J S Abrams; C L King; A P Limaye; T B Nutman
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

8.  Cardiovascular features of 11 patients with eosinophilic endomyocardial disease.

Authors:  J Davies; C J Spry; R Sapsford; E G Olsen; G de Perez; C M Oakley; J F Goodwin
Journal:  Q J Med       Date:  1983

9.  T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome.

Authors:  A Raghavachar; S Fleischer; N Frickhofen; H Heimpel; B Fleischer
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

10.  Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.

Authors:  E J Clutterbuck; E M Hirst; C J Sanderson
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

View more
  6 in total

1.  Interleukin-3-producing CD4+ T-cells support eosinophil survival in a patient with transient hypereosinophilia.

Authors:  Shin-ichi Toyabe; Waka Harada; Makoto Uchiyama
Journal:  Eur J Pediatr       Date:  2003-10-14       Impact factor: 3.183

2.  New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

Authors:  T Berki; M Dávid; B Bóné; H Losonczy; J Vass; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Synthesis of {alpha}(1,3) fucosyltransferases IV- and VII-dependent eosinophil selectin ligand and recruitment to the skin.

Authors:  Takahiro Satoh; Yasumasa Kanai; Ming-Hua Wu; Hiroo Yokozeki; Reiji Kannagi; John B Lowe; Kiyoshi Nishioka
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  [Spectrum of hypereosinophilia syndrome based on 2 clinical case reports].

Authors:  H Nolte; U Helmchen
Journal:  Med Klin (Munich)       Date:  1998-07-15

5.  Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.

Authors:  T Satoh; A Knowles; M S Li; L Sun; J A Tooze; G Zabucchi; C J Spry
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 6.  Role of Exercise Intensity on Th1/Th2 Immune Modulations During the COVID-19 Pandemic.

Authors:  Rashmi Supriya; Yang Gao; Yaodong Gu; Julien S Baker
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.